Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Birth Control Health Center

Font Size

FDA: Stronger Labeling Needed for Newer Contraceptives

Dangerous Blood-Clot Risks Need to Be More Prominent on Future Labels

No More Effective continued...

In the FDA study, women on Yasmin were twice as likely to have acne, which can be a characteristic of PCOS, than those on older birth control pills, Ouellett-Hellstrom said. PCOS alone puts women at a higher risk of blood clots.

Obesity can also raise women’s risk of blood clots. David Grimes, MD, said obese women are 60% to 80% more likely to be prescribed an oral contraceptive containing drospirenone than non-obese women. Grimes, a clinical professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill, was paid by Bayer to speak on behalf of its contraceptives at the advisory committee meeting.

Labeling Changes May Be Needed

Although the panel voted to keep the newer pills on the market, there was a strong divide among the experts.

Panelist Almut Winterstein, PhD, associate professor at the University of Florida College of Pharmacy, said the data also suggest Yasmin users are younger and healthier, so the increased risk of blood clots might actually be higher than the research has found. All birth control pills that contain estrogen and a progestin, including drospirenone, have a boxed warning on their labels about the risk of serious heart and blood-vessel problems such as blood clots in smokers over age 35.

The panel was nearly unanimous in saying the label on drospirenone contraceptives should explain even more clearly that some studies suggest they increase the risk of blood clots. But panelists questioned how to make that information comprehensible to doctors, let alone patients.

The FDA has not set a date to discuss the wording of the new labels.

1 | 2

Today on WebMD

Here's what to expect.
man opening condom wrapper
Do you know the right way to use them?
birth control pills
Here's what to do next.
doctor and patient
His and her options.
Concerned teenage girl
hospital gown
Birth Control Pills Weight Gain
Ortho Evra Birth Control Patch
contraceptive pills
Young couple looking at each other, serious
woman reading pregnancy test result